AMBALAL SARABHAI ENT L Share Price
AMBALAL SARABHAI ENT L Share Price Today
As of 5 Jul 2026, AMBALAL SARABHAI ENT L share price is ₹32.82. The stock opened at ₹31.90, compared to its previous close of ₹31.91. During today's trading session, AMBALAL SARABHAI ENT L share price moved in the range of ₹31.63 to ₹33.59, with an average price of ₹32.61 for the day. Looking at its last 52-week, the stock has touched a low of ₹30.30 and a high of ₹38.50. On the performance front, AMBALAL SARABHAI ENT L share price has declined by 6.89% over the last six months and is down 6.89% on a year-on-year basis.
AMBALAL SARABHAI ENT L Returns Calculator
AMBALAL SARABHAI ENT L Shareholder Returns
AMBALAL SARABHAI ENT L Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
AMBALAL SARABHAI ENT L Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹196.19 | ₹173.57 | ₹170.28 | ₹196.75 |
| Other Income | ₹11.38 | ₹10.37 | ₹12.49 | ₹42.02 |
| Total Revenue | ₹207.57 | ₹183.95 | ₹182.77 | ₹238.76 |
| Total Expenses | ₹196.38 | ₹174.58 | ₹166.91 | ₹175.87 |
| Profit Before Tax | ₹4.83 | ₹6.65 | ₹15.17 | ₹54.19 |
| Tax | -₹0.10 | ₹0.97 | ₹3.72 | ₹6.98 |
| Profit After Tax | ₹4.93 | ₹5.68 | ₹11.45 | ₹47.22 |
| EPS - Basic | ₹0.64 | ₹0.74 | ₹1.49 | ₹6.16 |
| EPS - Diluted | ₹0.64 | ₹0.74 | ₹1.49 | ₹6.16 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹4.83 | ₹6.65 | ₹15.17 | ₹54.19 |
| Income before WC changes | ₹7.04 | ₹11.12 | ₹14.57 | ₹34.37 |
| Change in Assets | -₹38.35 | ₹0.42 | -₹0.96 | -₹7.94 |
| Change in Liabilities | ₹16.91 | ₹1.35 | -₹3.48 | -₹11.40 |
| Change in WC | -₹21.43 | ₹1.77 | -₹4.43 | -₹19.35 |
| Cash flow from Operations | -₹17.62 | ₹8.89 | ₹5.72 | ₹11.47 |
| Cash flow from Investing | ₹13.26 | -₹5.30 | -₹16.78 | ₹5.08 |
| Cash flow from Financing | -₹1.53 | -₹2.95 | ₹9.09 | -₹19.19 |
| Total Cash Flow | -₹5.88 | ₹0.65 | -₹1.97 | -₹2.64 |
| Cash (Start of the year) | ₹10.78 | ₹10.13 | ₹12.10 | ₹14.74 |
| Cash (End of the year) | ₹4.89 | ₹10.78 | ₹10.13 | ₹12.10 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹151.56 | ₹130.98 | ₹134.80 | ₹110.31 |
| Current Assets | ₹118.48 | ₹118.54 | ₹110.94 | ₹120.19 |
| Total Assets | ₹270.04 | ₹249.52 | ₹245.74 | ₹230.50 |
| Current Liabilities | ₹120.40 | ₹102.32 | ₹102.87 | ₹105.47 |
| Net Current Asset | -₹1.92 | ₹16.23 | ₹8.07 | ₹14.72 |
| Non-Current Liabilities | ₹9.66 | ₹10.78 | ₹11.94 | ₹5.18 |
| Equity Capital | ₹139.98 | ₹136.42 | ₹130.93 | ₹119.86 |
| Total Equity & Liabilities | ₹270.04 | ₹249.52 | ₹245.74 | ₹230.50 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹4.04 | ₹3.81 | ₹3.71 | ₹0.13 |
| Other Income | ₹15.29 | ₹7.89 | ₹10.53 | ₹39.54 |
| Total Revenue | ₹19.33 | ₹11.70 | ₹14.24 | ₹39.66 |
| Total Expenses | ₹11.81 | ₹10.89 | ₹9.12 | ₹6.13 |
| Profit Before Tax | ₹8.08 | ₹0.81 | ₹4.34 | ₹3.45 |
| Tax | -₹0.16 | -₹1.77 | ₹0.23 | ₹0.50 |
| Profit After Tax | ₹8.24 | ₹2.58 | ₹4.11 | ₹2.96 |
| EPS - Basic | ₹1.08 | ₹0.34 | ₹0.54 | ₹0.39 |
| EPS - Diluted | ₹1.08 | ₹0.34 | ₹0.54 | ₹0.39 |
Cash Flow · Standalone
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|
| Profit before tax | ₹0.81 | ₹4.34 | ₹3.45 | -₹9.47 |
| Income before WC changes | -₹3.16 | -₹1.37 | ₹2.32 | -₹7.93 |
| Change in Assets | -₹1.91 | ₹2.70 | -₹2.45 | -₹0.31 |
| Change in Liabilities | ₹1.93 | ₹0.98 | -₹7.03 | -₹1.75 |
| Change in WC | ₹0.02 | ₹3.68 | -₹9.49 | -₹2.06 |
| Cash flow from Operations | -₹3.82 | ₹1.52 | -₹7.79 | -₹10.42 |
| Cash flow from Investing | ₹3.48 | ₹0.61 | ₹20.77 | ₹15.76 |
| Cash flow from Financing | ₹0.30 | -₹3.76 | -₹16.46 | -₹0.32 |
| Total Cash Flow | -₹0.04 | -₹1.63 | -₹3.47 | ₹5.02 |
| Cash (Start of the year) | ₹0.17 | ₹1.80 | ₹5.27 | ₹0.25 |
| Cash (End of the year) | ₹0.13 | ₹0.17 | ₹1.80 | ₹5.27 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹44.30 | ₹44.79 | ₹45.35 | ₹40.40 |
| Current Assets | ₹38.62 | ₹36.49 | ₹34.40 | ₹42.59 |
| Total Assets | ₹82.92 | ₹81.28 | ₹79.74 | ₹82.99 |
| Current Liabilities | ₹34.12 | ₹40.65 | ₹41.49 | ₹48.42 |
| Net Current Asset | ₹4.50 | -₹4.16 | -₹7.09 | -₹5.84 |
| Non-Current Liabilities | ₹0.30 | ₹0.34 | ₹0.41 | ₹0.86 |
| Equity Capital | ₹48.49 | ₹40.29 | ₹37.85 | ₹33.70 |
| Total Equity & Liabilities | ₹82.92 | ₹81.28 | ₹79.74 | ₹82.99 |
About AMBALAL SARABHAI ENT L
Ambalal Sarabhai Enterprises Limited is an India-based company that is engaged in the business of manufacturing pharmaceuticals and electronics. The Company's segments include Pharmaceuticals and Electronics. Asence Inc., a wholly owned subsidiary of the Company, specializes in the supply of pharmaceutical preparations (finished dosage forms and active pharmaceutical ingredients) to the international markets. Its subsidiary, Sarabhai Chemicals (India) Private Limited, offers products in the oncology, infertility and Uro-gynaec areas. Its wholly owned subsidiary, Suvik Hitek Pvt. Ltd., is engaged in manufacturing pharmaceutical products and marketing generics and veterinary products in the domestic market. Its subsidiary, Systronics (India) Limited, is a manufacturer of analytical and test and measuring instruments, distributing its products across India. Its other subsidiaries include Synbiotics Limited, Asence Pharma Private Limited, and Sarabhai M Chemicals Limited, among others.
AMBALAL SARABHAI ENT L Financial Highlights
- Revenue: AMBALAL SARABHAI ENT L reported revenue of ₹217.44 crore in FY26 vs ₹207.57 crore in FY25. It showed an increase of 4.76% on a yearly basis.
- Operating Profit: AMBALAL SARABHAI ENT L reported an operating profit of ₹18.51 crore in FY26 vs ₹4.83 crore in FY25. It showed an increase of 283.23% on a year-on-year basis.
- Net Profit: AMBALAL SARABHAI ENT L reported a net profit of ₹17.80 crore in FY26 vs ₹4.93 crore in FY25. It showed an increase of 261.05% on a yearly basis.
AMBALAL SARABHAI ENT L Quarterly Result Highlights
- AMBALAL SARABHAI ENT L reported revenue of ₹68.10 crore in Mar 2026, compared with ₹54.58 crore in Dec 2025, representing an increase of 24.77% on a quarter-on-quarter (QoQ) basis.
- AMBALAL SARABHAI ENT L reported an operating profit of ₹6.25 crore in Mar 2026, compared with ₹4.36 crore in Dec 2025, representing an increase of 43.35% on a quarter-on-quarter (QoQ) basis.
- AMBALAL SARABHAI ENT L reported a profit of ₹6.50 crore in Mar 2026, compared with ₹3.64 crore in Dec 2025, reflecting an increase of 78.57% on a QoQ basis.
- The earnings per share (EPS) of AMBALAL SARABHAI ENT L stood at ₹0.64 during Mar 2026.
Similar Stocks
FAQs on AMBALAL SARABHAI ENT L Share Price
What is AMBALAL SARABHAI ENT L share price today?
AMBALAL SARABHAI ENT L share price is ₹32.82 as on 03 Jul, 2026, 15:48 IST.
How has the AMBALAL SARABHAI ENT L share price performed in the past?
In the last 1 year, AMBALAL SARABHAI ENT L delivered a return of -6.89%. The AMBALAL SARABHAI ENT L share price hit a high of ₹38.50 and low of ₹30.30.
How much is the Mutual Fund shareholding in AMBALAL SARABHAI ENT L shares?
The Mutual Fund Shareholding in AMBALAL SARABHAI ENT L was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of AMBALAL SARABHAI ENT L shares ?
The 52-week high and low of AMBALAL SARABHAI ENT L share is ₹38.50 and ₹30.30 as of 03 Jul, 2026.
What is the market cap of AMBALAL SARABHAI ENT L?
The market capitalisation of AMBALAL SARABHAI ENT L is ₹243.85 Crores as on 03 Jul, 2026.
What are the stock symbols of AMBALAL SARABHAI ENT L?
The stock symbol of AMBALAL SARABHAI ENT L is AMBALALSA on the NSE, 500009 on the BSE, and the ISIN is INE432A01017.
What was yesterday's closing price of AMBALAL SARABHAI ENT L shares ?
AMBALAL SARABHAI ENT L shares closed yesterday at ₹31.91 on NSE & ₹31.82 on BSE
How to buy AMBALAL SARABHAI ENT L shares?
To buy AMBALAL SARABHAI ENT L shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy AMBALAL SARABHAI ENT L shares on Holidays?
No, shares of AMBALAL SARABHAI ENT L or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell AMBALAL SARABHAI ENT L shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of AMBALAL SARABHAI ENT L?
The PE and PB ratio of AMBALAL SARABHAI ENT L is 13.72 and 1.54 respectively, as on 03 Jul, 2026, 15:48 IST.